A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
Public ClinicalTrials.gov record NCT04516278. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders, NORSE THREE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will evaluate the safety of ophthalmic bevacizumab in subjects diagnosed with a retinal condition that would benefit from treatment with intravitreal injection of bevacizumab, including: exudative age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion.
Study identification
- NCT ID
- NCT04516278
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 197 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 2020 (Actual)
- Primary completion
- Feb 10, 2021 (Actual)
- Completion
- Feb 10, 2021 (Actual)
- Last update posted
- Jul 17, 2026
2020 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Tucson | Arizona | 85710 | — |
| Clinical Site | Beverly Hills | California | 90211 | — |
| Clinical Site | Glendale | California | 91203 | — |
| Clinical Site | Long Beach | California | 90807 | — |
| Clinical Site | Palm Desert | California | 92260 | — |
| Clinical Site | Poway | California | 92064 | — |
| Clinical Site | Clearwater | Florida | 33761 | — |
| Clinical Site | Winter Haven | Florida | 33880 | — |
| Clinical Site | Oak Forest | Illinois | 60452 | — |
| Clinical Site | Springfield | Illinois | 62704 | — |
| Clinical Site | Hagerstown | Maryland | 21740 | — |
| Clinical Site | Albuquerque | New Mexico | 87109 | — |
| Clinical Site | Chambersburg | Pennsylvania | 17201 | — |
| Clinical Site | Rapid City | South Dakota | 57701 | — |
| Clinical Site | Germantown | Tennessee | 38138 | — |
| Clinical Site | Abilene | Texas | 79606 | — |
| Clinical Site | Arlington | Texas | 76012 | — |
| Clinical Site | McAllen | Texas | 78503 | — |
| Clinical Site | San Antonio | Texas | 78251 | — |
| Clinical Site | Willow Park | Texas | 76087 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04516278, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04516278 live on ClinicalTrials.gov.